GO
Loading...

Allergan Inc

More

  • Midday Glance: Medical Devices companies Friday, 28 Nov 2014 | 2:11 PM ET

    Allergan fell$. 05 or percent, to $213.95. Baxter International Inc. rose$. 59 or. 8 percent, to $72.99. Boston Scientific Corp. rose$. 07 or. 5 percent, to $12.88.

  • Early Glance: Medical Devices companies Friday, 28 Nov 2014 | 10:28 AM ET

    Allergan rose$. 13 or. 1 percent, to $214.13. Baxter International Inc. rose$. 66 or. 9 percent, to $73.06. Johnson& Johnson rose $1.18 or 1.1 percent, to $108.39.

  • Final Glance: Medical Devices companies Wednesday, 26 Nov 2014 | 6:02 PM ET

    Allergan rose $1.90 or. 9 percent, to $214.00. Baxter International Inc. fell$. 04 or. 1 percent, to $72.40. Boston Scientific Corp. fell$. 05 or. 4 percent, to $12.81.

  • Midday Glance: Medical Devices companies Wednesday, 26 Nov 2014 | 2:02 PM ET

    Allergan rose$. 75 or. 4 percent, to $212.85. Baxter International Inc. fell$. 02 or percent, to $72.42. Boston Scientific Corp. fell$. 06 or. 5 percent, to $12.80.

  • Early Glance: Medical Devices companies Wednesday, 26 Nov 2014 | 10:24 AM ET

    Allergan rose $1.61 or. 8 percent, to $213.71. Baxter International Inc. fell$. 03 or percent, to $72.41. Boston Scientific Corp. rose$. 02 or. 2 percent, to $12.88.

  • BOSTON, Nov 26- Hedge fund mogul William Ackman told investors they could see a $6 billion payday when he closes the chapter on Allergan Inc., his firm's biggest bet of 2014.. One week after Allergan agreed to sell itself to rival Actavis Plc., Ackman wrote in his quarterly investment letter that his Pershing Square Capital Management, the Botox-maker's biggest...

  • Final Glance: Medical Devices companies Tuesday, 25 Nov 2014 | 6:57 PM ET

    Allergan rose$. 29 or. 1 percent, to $212.10. Boston Scientific Corp. fell$. 28 or 2.1 percent, to $12.86. Johnson& Johnson fell$. 18 or. 2 percent, to $106.70.

  • Midday Glance: Medical Devices companies Tuesday, 25 Nov 2014 | 1:18 PM ET

    Allergan rose$. 92 or. 4 percent, to $212.73. Baxter International Inc. rose$. 03 or percent, to $72.47. Boston Scientific Corp. fell$. 38 or 2.9 percent, to $12.76.

  • Early Glance: Medical Devices companies Tuesday, 25 Nov 2014 | 10:22 AM ET

    Allergan rose$. 94 or. 4 percent, to $212.75. Baxter International Inc. rose$. 01 or percent, to $72.45. Boston Scientific Corp. fell$. 07 or. 5 percent, to $13.07.

  • Final Glance: Medical Devices companies Monday, 24 Nov 2014 | 6:08 PM ET

    Allergan rose $2.72 or 1.3 percent, to $211.81. Boston Scientific Corp. rose$. 20 or 1.5 percent, to $13.14. St. Jude Medical Inc. rose $1.29 or 1.9 percent, to $68.09.

  • Early Glance: Medical Devices companies Monday, 24 Nov 2014 | 10:27 AM ET

    Allergan rose $1.22 or. 6 percent, to $210.31. Baxter International Inc. fell$. 07 or. 1 percent, to $72.37. Boston Scientific Corp. rose$. 08 or. 6 percent, to $13.02.

  • *RenaissanceRe to buy Platinum for $1.9 bln. NEW YORK, Nov 24- U.S. stock index futures pointed to a higher open on Monday, indicating that major indexes would move further into record territory on the back of multiple merger deals and hopes that China will take further accommodative monetary policy action. Equities closed a fifth straight week of advances Friday,...

  • US STOCKS-Futures rise, boosted by merger activity Monday, 24 Nov 2014 | 8:14 AM ET

    *RenaissanceRe to buy Platinum for $1.9 bln. NEW YORK, Nov 24- U.S. stock index futures rose on Monday, indicating that major indexes would move further into record territory, on the back of multiple merger deals and hopes that China will take further accommodative monetary policy action. Equities closed a fifth straight week of advances Friday, with the Dow and S&P...

  • Final Glance: Medical Devices companies Friday, 21 Nov 2014 | 6:02 PM ET

    Allergan fell $1.11 or. 5 percent, to $209.09. Baxter International Inc. rose$. 45 or. 6 percent, to $72.44. Boston Scientific Corp. fell$. 01 or. 1 percent, to $12.94.

  • Goldman Sachs Group Inc retained its No. 1 position as M&A adviser with deals worth $877 billion, followed by JPMorgan Chase& Co with $651 billion and Citigroup Inc with $633 billion. The $66.4 billion bid for Allergan Inc by Actavis PLC this week more than doubled the total value of deals in the healthcare sector to $364 billion. Halliburton Co's plans to buy...

  • Early Glance: Medical Devices companies Friday, 21 Nov 2014 | 10:17 AM ET

    Allergan rose$. 33 or. 2 percent, to $210.53. Baxter International Inc. rose$. 74 or 1.0 percent, to $72.73. Boston Scientific Corp. rose$. 13 or 1.0 percent, to $13.08.

  • CEOs in 10 big mergers to get $430M: Study Friday, 21 Nov 2014 | 8:20 AM ET
    David Pyott

    CEOs who decided to sell in the 10 biggest U.S. deals this year will rake in $430 million in "golden parachute" payments, according to a study.

  • Valeant slashes stake in Allergan after losing bid Thursday, 20 Nov 2014 | 7:14 PM ET

    Nov 20- Valeant Pharmaceuticals International Inc said it cut its stake in Allergan Inc to 0.1 percent from 9.7 percent, three days after Actavis Plc trumped its offer for the Botox maker. Pershing Square Capital Management informed Valeant that PS Fund 1 sold all of its 2.2 million shares in Allergan allocated to Valeant USA, Valeant said in a regulatory filing.

  • Final Glance: Medical Devices companies Thursday, 20 Nov 2014 | 6:02 PM ET

    Allergan fell $2.39 or 1.1 percent, to $210.20. Baxter International Inc. fell$. 47 or. 6 percent, to $71.99. Boston Scientific Corp. fell$. 14 or 1.1 percent, to $12.95.

  • Family gets $6.75 million in Botox treatment case Thursday, 20 Nov 2014 | 3:41 PM ET

    The verdict, in U.S. District Court in Burlington, came three days after the announcement that Parsippany, New Jersey- based drugmaker Actavis would acquire Botox maker Allergan for $66 billion, one of the biggest acquisitions announced this year. Thursday's verdict came four years after Irvine, California- based Allergan agreed to pay $600 million, pleading...